Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Indivior ( (INDV) ) just unveiled an announcement.
Indivior PLC announced it will release its second quarter 2025 financial results on July 31, 2025, followed by a live webcast presentation led by CEO Joe Ciaffoni and other executives. This announcement is significant for stakeholders as it provides insights into the company’s financial health and strategic direction, reinforcing its commitment to addressing opioid use disorder.
More about Indivior
Indivior is a global pharmaceutical company focused on developing medicines to treat opioid use disorder (OUD). With a vision to provide evidence-based treatment for OUD worldwide, Indivior aims to transform OUD from a global crisis to a recognized chronic disease. The company, headquartered in Richmond, VA, employs over 1,000 people globally and offers its products in over 30 countries.
See more insights into INDV stock on TipRanks’ Stock Analysis page.